Is Methylene Blue Safe to Take Daily? A Science-Backed Answer

Is methylene blue safe to take daily? The honest, science-based answer is that nobody knows for certain, because no one has run a long-term safety trial of small daily servings in healthy people. What the science does give us is enough to say who must not take it at all, what happens in the body with repeated doses, and how to keep the risk low if you choose to take it.

This guide sets out that evidence: the human trials, the longest repeated-dosing data, what mainstream medical sources say, the interactions and conditions that rule methylene blue out, and a cautious daily routine. NooBlue sells methylene blue capsules, gummies and drops, so we have a commercial interest in the answer. We have tried to report the evidence as it stands, including where it runs out. Written by the NooBlue editorial team.

The Short Answer

For a healthy adult who takes none of the interacting medicines and does not have G6PD deficiency, a small daily serving at the label dose has no known specific harm. That is not the same as proven long-term safety. The human evidence is short-term or comes from related compounds at far higher doses, and the risks that are well documented (serotonin toxicity, red blood cell damage in G6PD deficiency, harm in pregnancy) are serious. So the answer depends on who you are:

• If any warning in the safety section applies to you, do not take methylene blue daily or at all without your doctor.
• If none applies, daily use at the label serving is a personal choice made with incomplete data. Keep the dose small, keep your doctor and pharmacist informed, and stop if anything changes.

Our broader guide to whether methylene blue is good for you covers the benefit side of the question.

What the Science Shows About Daily Use

Single-dose human trials

The best-known human studies gave methylene blue once. In a randomized, double-blind, placebo-controlled trial, 26 healthy adults took a single oral dose of 280 mg, about 4 mg/kg. One hour later, functional MRI showed stronger responses during attention and memory tasks, and correct memory-retrieval responses rose by 7% (Rodriguez et al., Radiology, 2016). A 2017 follow-up with the same single 280 mg dose found changes in brain connectivity (Rodriguez et al., 2017). These trials show that oral methylene blue reaches the brain. They say nothing about taking it every day for months.

The longest repeated-dosing data

The largest long-term dataset on a methylene blue compound taken by mouth every day comes from a 15-month phase 3 trial in 891 older adults with memory decline. The compound was LMTM, a stable reduced form of the same methylthioninium molecule, not the methylene blue chloride sold as a supplement. Participants took 75 mg or 125 mg twice a day, and a control group of 357 took 4 mg twice a day so that everyone’s urine was tinted and the trial stayed blinded (Gauthier et al., Lancet, 2016).

The trial found no benefit on its main outcomes. On safety, stomach and urinary effects were the most common adverse events at both high doses, and the most common reasons people stopped. The most common lab finding was a small, dose-dependent drop in hemoglobin that the authors judged not clinically significant. Three cautions apply: the participants were older and could take other medicines, the high doses were many times a supplement serving, and LMTM is a different salt with its own absorption profile (Baddeley et al., 2015). The control group’s 4 mg twice a day is the closest the trial came to supplement amounts, and that arm was there for blinding, not to test safety in healthy people.

What repeated dosing does in the body

The prescribing information for ProvayBlue, a prescription methylene blue injection, gives a half-life of about 24 hours in humans (ProvayBlue prescribing information). With a once-daily dose, part of yesterday’s dose is still in your body when you take today’s, so levels build over the first several days before they level off. That is one reason to stay at the label serving rather than adding extra doses. Our methylene blue half-life guide works through the numbers, and our page on methylene blue absorption covers how much of a dose reaches the blood.

More is not better with methylene blue. A review of the animal memory research describes a hormetic dose response, with opposite effects at low and high doses (Rojas et al., Progress in Neurobiology, 2012). The body also turns part of each dose into azure B, a metabolite that inhibits the enzyme MAO-A about six times more potently than methylene blue in lab tests (Petzer et al., 2012). No one has measured how much MAO-A inhibition a daily 5 mg serving produces, which is why the interaction rules below apply every day you take it.

What Mainstream Medical Sources Say

Harvard Health Publishing’s 2025 article, reviewed by Robert H. Shmerling, MD, draws a sharp line between a “pharmaceutical-grade product in a controlled setting” and “buying an unregulated supplement off the internet and taking it every day.” It warns that adding methylene blue to antidepressants such as fluoxetine or duloxetine “can result in a dangerous and sometimes fatal interaction,” and that industrial or chemical-grade methylene blue “should not be used in humans or animals” (Goldman, Harvard Health, 2025).

A 2022 narrative review in Toxicology Research goes further. It concludes that the basic toxicological characteristics of methylene blue are unknown, and that its toxic effects are dose-dependent, including red blood cell breakdown, nausea and vomiting, chest pain and shortness of breath (Bužga et al., 2022).

We think both sources deserve to be taken seriously. Where we add context is scale and grade. The effects in that review come from clinical doses, usually given into a vein, and a 5 mg capsule is a small fraction of those amounts. The quality warning is also why grade matters: our guides to lab grade vs pharmaceutical grade methylene blue and reading a certificate of analysis explain what to check. For the question of why doctors rarely suggest it, see why doctors don’t prescribe methylene blue.

Who Should Not Take Methylene Blue Daily

These rules apply to every format and every dose. Taking methylene blue daily makes them more important, not less.

• Anyone taking serotonergic medicines. Methylene blue is a potent, reversible MAO-A inhibitor (Ramsay et al., 2007). A systematic review found 26 patients who developed an acute confusional state after a methylene blue infusion. Of those, 24 were taking a serotonin reuptake inhibitor and one was taking clomipramine, and serotonin syndrome was a possible diagnosis in all 25 (Ng and Cameron, Psychosomatics, 2010). The ProvayBlue label lists SSRIs, SNRIs, MAOIs, bupropion, buspirone, clomipramine, mirtazapine, linezolid, opioids and dextromethorphan among the drugs to avoid.
• Anyone taking prescription stimulants or atomoxetine. The Adderall XR, Vyvanse and Strattera labels all name intravenous methylene blue among the MAO inhibitors those drugs must not be combined with, or taken within 14 days of (Adderall XR label).
• People with G6PD deficiency. The injection is contraindicated in G6PD deficiency because of the risk of hemolytic anemia. If you do not know your status, ask your doctor about a test first. See our G6PD guide.
• Anyone pregnant or breastfeeding. The label states that methylene blue may cause fetal harm, and advises stopping breastfeeding during treatment and for up to 8 days afterwards.
• People with kidney or liver problems. After a single 1 mg/kg IV dose, exposure rose by 52%, 116% and 192% in mild, moderate and severe kidney impairment, and the label advises longer monitoring in any liver impairment. Talk to your doctor first. Our page on methylene blue and the liver has more.
• Anyone under 18. Methylene blue supplements are for adults.

For the full picture, see who should not take methylene blue, what not to take with methylene blue, our interactions guide and our page on methylene blue and serotonin syndrome. If you take a prescription stimulant, our comparison of methylene blue vs Adderall explains the interaction.

What to Expect With Daily Use, and When to Stop

Expected and harmless

• Blue or blue-green urine. About 40% of methylene blue leaves in the urine unchanged, and the label says the dye “passes freely into the urine.” It can also tint skin and other body fluids. See our guide to methylene blue urine color.
• Tongue or mouth staining with drops and gummies. How much varies from person to person and with how you take it.

Worth telling a doctor about

• Urine tests. The label warns that methylene blue can interfere with urine tests that rely on a blue indicator, such as the dipstick test for leukocyte esterase.
• Oxygen monitoring. The label advises using methods other than pulse oximetry to assess oxygen levels after the injection. If you are having surgery or a hospital procedure, tell the team you take methylene blue.
• Stomach upset. Stomach effects were the most common adverse events at the high doses in the 15-month trial. If they persist at a supplement serving, stop and ask your doctor.

Stop and get medical help

The label lists the signs of serotonin syndrome as including agitation, hallucinations, a fast heart rate, sweating, flushing, fever, tremor, muscle rigidity and loss of coordination. If you notice these, especially after starting or changing any medicine, stop methylene blue and get urgent care. Our methylene blue side effects guide covers the full list.

A Cautious Daily Routine

If none of the warnings applies to you, these habits keep the risk as low as the evidence allows:

• Stay at the label serving. Our capsule label says one capsule daily with food, and the gummy label says one gummy daily. With drops, 10 drops make 5 mg. Our guide to how many mg of methylene blue per day covers daily amounts.
• Do not stack formats. A capsule plus a gummy plus drops adds up. Count your total.
• Keep it consistent. Same time, same way, each day, so you can tell whether anything changes.
• Keep your doctor and pharmacist informed, and recheck the interaction list whenever a new medicine is added.
• Take breaks if you like. No study shows that cycling is needed or helpful. A pause does let you judge whether you notice any difference.

For measuring and mixing drops, see our guide to taking methylene blue drops.

Choosing a Format for Daily Use

Prices as of Sep 2026.

For daily use, the 5 mg capsule is the simplest fixed serving. The drops let you adjust in 0.5 mg steps, and the gummies carry the largest single serving at 10 mg. Contract Testing Laboratories of America analyzed our methylene blue ingredient for identity and four heavy metals. That report covers the raw ingredient, not each finished batch, and it does not state a purity percentage. You can read it on our quality page. Everything we make is in the NooBlue shop, and if you are comparing brands, our best methylene blue supplements roundup sets out the options.

The Bottom Line

Methylene blue has not been proven safe for years of daily use, and it has not been shown to be harmful at small daily servings in healthy adults either. The dangers that are documented are specific: serotonergic and stimulant medicines, G6PD deficiency, pregnancy and breastfeeding, and kidney or liver problems. If none applies, staying at the label serving, keeping your doctor informed and stopping at the first sign of trouble is the cautious way to take it. For background on the research, see our overview of methylene blue for brain and cellular health, and our comparisons with CoQ10 and NMN.

Frequently Asked Questions

What happens if I take methylene blue every day?

With a half-life of about 24 hours, levels build over the first several days and then level off. Your urine will be tinted blue or blue-green. Beyond that, no trial has followed healthy adults on small daily servings, so long-term effects are unknown. In a 15-month trial of a related compound at much higher doses, stomach and urinary effects were the most common problems.

Why don’t doctors recommend methylene blue?

Methylene blue is a prescription injection with specific hospital uses, and there are no large trials of daily oral supplements in healthy people. Doctors also know its interaction with serotonergic medicines can be dangerous. Harvard Health’s 2025 article reflects that caution.

Can taking methylene blue be harmful?

Yes, in the wrong person or at the wrong dose. It can cause serotonin syndrome with serotonergic medicines, hypertensive crisis risk with some stimulant medicines, red blood cell damage in G6PD deficiency, and harm in pregnancy. A 2022 review describes dose-dependent toxic effects at clinical doses. Do not take it if any of the warnings applies to you.

Why do I feel so good on methylene blue?

No study has measured how people feel on 5 or 10 mg a day, so we cannot explain an individual response. Methylene blue does inhibit MAO-A, the enzyme behind its serotonin interaction, so a clear change in mood is a reason to review your other medicines with a doctor or pharmacist, not a reason to raise the dose.

How long does methylene blue stay in your system?

The injection’s label gives a half-life of about 24 hours, so half of a dose is still present a day later. That is why daily doses overlap.

Will my urine always be blue if I take it daily?

Usually, because about 40% of each dose leaves in the urine unchanged. How strong the color looks depends on the dose and how much you drink. A pale color is not a sign that a product is fake or that you absorbed nothing.

Can I combine daily methylene blue with other supplements?

Avoid anything that raises serotonin, and ask a pharmacist before you add any supplement sold for mood. The prescription drugs to avoid are listed in the safety section above. For common pairings, see our comparisons with CoQ10 and NMN.

How many drops of methylene blue should I take daily?

With a 1% solution such as NooBlue drops, each drop carries 0.5 mg, so 10 drops make one 5 mg serving. Follow the label on the bottle you buy, because concentrations differ between brands, and do not take methylene blue at all if any of the warnings applies to you.

Sources

1. Rodriguez P, Zhou W, Barrett DW, et al. Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. 2016;281(2):516-526. PubMed 27351678
2. Rodriguez P, Singh AP, Malloy KE, et al. Methylene blue modulates functional connectivity in the human brain. Brain Imaging and Behavior. 2017;11(3):640-648. PubMed 26961091
3. Gauthier S, Feldman HH, Schneider LS, et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer’s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet. 2016;388(10062):2873-2884. PubMed 27863809
4. Baddeley TC, McCaffrey J, Storey JM, et al. Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer’s disease. Journal of Pharmacology and Experimental Therapeutics. 2015;352(1):110-118. PubMed 25320049
5. Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Progress in Neurobiology. 2012;96(1):32-45. PubMed 22067440
6. Petzer A, Harvey BH, Wegener G, Petzer JP. Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase. Toxicology and Applied Pharmacology. 2012;258(3):403-409. PubMed 22197611
7. Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology. 2007;152(6):946-951. PubMed 17721552
8. Ng BK, Cameron AJ. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics. 2010;51(3):194-200. PubMed 20484716
9. Bužga M, Machytka E, Dvořáčková E, et al. Methylene blue: a controversial diagnostic acid and medication? Toxicology Research. 2022;11(5):711-717. PubMed 36337249
10. Goldman L. What to know about methylene blue. Harvard Health Publishing, April 24, 2025. health.harvard.edu
11. ProvayBlue (methylene blue) injection prescribing information, revised 2/2024. DailyMed
12. Adderall XR (mixed amphetamine salts) prescribing information, revised 4/2026. DailyMed
13. Vyvanse (lisdexamfetamine dimesylate) prescribing information, revised 4/2026. DailyMed
14. Strattera (atomoxetine) prescribing information, revised 6/2026. DailyMed
15. NooBlue product pages and quality page (label amounts, directions and the CTLA ingredient report), read Sep 2026. nooblue.com/quality